Merck KGaA (OTCMKTS:MKGAF) Shares Down 7.1% – Should You Sell?

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s share price traded down 7.1% during mid-day trading on Wednesday . The stock traded as low as $147.8610 and last traded at $147.8610. 195 shares were traded during mid-day trading, a decline of 62% from the average session volume of 507 shares. The stock had previously closed at $159.2210.

Merck KGaA Stock Down 3.9%

The company has a market capitalization of $19.57 billion, a P/E ratio of 23.12 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock’s fifty day moving average is $145.66 and its 200 day moving average is $136.35.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.